Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis
- PMID: 20052998
- DOI: 10.1021/pr900825t
Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis
Abstract
The transformation of a normal cell into a cancer cell has been correlated with alterations in gene regulation and protein expression. To identify altered proteins and link them to the tumorigenesis of breast cancer, we have distinguished normal breast cells (MCF-10A) from noninvasive breast cancer cells (MCF-7) and invasive breast cancer cells (MB-MDA-231) to identify potential breast cancer markers in transformed breast cells. Using the 2D-DIGE and MALDI-TOF MS techniques, we quantified and identified differentially expressed extracellular secreted proteins and total cellular proteins across MCF-7, MB-MDA-231 and MCF-10A. The proteomic analysis of the secreted proteins identified 50 unique differentially expressed proteins from three different media. In addition, 133 unique differentially expressed proteins from total cellular proteins were also identified. Note that 14 of the secreted proteins and 51 of the total cellular proteins have not been previously reported in breast cancer research. Some of these unreported proteins have been examined in other breast cancer cell lines and have shown positive correlations with 2D-DIGE data. In summary, this study identifies numerous putative breast cancer markers from various stages of breast cancer. The results of this study may aid in developing proteins identified as useful diagnostic and therapeutic candidates in research on cancer and proteomics.
Similar articles
-
Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.J Proteome Res. 2008 Apr;7(4):1518-28. doi: 10.1021/pr700820g. Epub 2008 Mar 5. J Proteome Res. 2008. PMID: 18318472
-
Identification of proteins secreted from leptin stimulated MCF-7 breast cancer cells: a dual proteomic approach.Exp Biol Med (Maywood). 2008 Jun;233(6):708-20. doi: 10.3181/0710-RM-281. Epub 2008 Apr 11. Exp Biol Med (Maywood). 2008. PMID: 18408141
-
Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.Clin Cancer Res. 2005 Nov 15;11(22):8006-14. doi: 10.1158/1078-0432.CCR-05-0632. Clin Cancer Res. 2005. PMID: 16299229
-
Clinical proteomics in breast cancer: a review.Breast Cancer Res Treat. 2009 Jul;116(1):17-29. doi: 10.1007/s10549-008-0263-3. Epub 2008 Dec 11. Breast Cancer Res Treat. 2009. PMID: 19082706 Review.
-
The evolving role of proteomics in the early detection of breast cancer.Int J Fertil Womens Med. 2005 Sep-Oct;50(5 Pt 1):212-6. Int J Fertil Womens Med. 2005. PMID: 16468471 Review.
Cited by
-
Reduced selenium-binding protein 1 in breast cancer correlates with poor survival and resistance to the anti-proliferative effects of selenium.PLoS One. 2013 May 21;8(5):e63702. doi: 10.1371/journal.pone.0063702. Print 2013. PLoS One. 2013. PMID: 23704933 Free PMC article.
-
Proteome differences between male and female fetal cells in amniotic fluid.OMICS. 2013 Jan;17(1):16-26. doi: 10.1089/omi.2010.0145. Epub 2012 Mar 9. OMICS. 2013. PMID: 22404150 Free PMC article.
-
Exosomes released from breast cancer carcinomas stimulate cell movement.PLoS One. 2015 Mar 23;10(3):e0117495. doi: 10.1371/journal.pone.0117495. eCollection 2015. PLoS One. 2015. PMID: 25798887 Free PMC article.
-
The MDA-MB-231 Breast Cancer Cell Secretomes Modify Metabolomes of Pseudomonas aeruginosa Breast Microbiome.Int J Mol Sci. 2025 May 22;26(11):5003. doi: 10.3390/ijms26115003. Int J Mol Sci. 2025. PMID: 40507816 Free PMC article.
-
Targeting proteomics to investigate metastasis-associated mitochondrial proteins.J Bioenerg Biomembr. 2012 Dec;44(6):629-34. doi: 10.1007/s10863-012-9466-8. J Bioenerg Biomembr. 2012. PMID: 22890579 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous